Tags : LifeArc


Cumulus Neuroscience secures £6 million Seed Follow On investment led

Cumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund Proceeds to be used to advance next-generation integrated physiological and digital biomarker platform that provides clinical trial data and AI-powered insights, to accelerate the development of life-changing CNS therapies Platform addresses the significant unmet need for […]Read More


Ikarovec secures £2.5 million seed funding led by UK Innovation

Ophthalmic gene therapy company Ikarovec launches with £2.5m seed funding Founded by UK Innovation & Science Seed Fund (UKI2S) with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products Cambridge, February 5 2020: Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has launched today […]Read More